NCL, for the first time establishes the triangular link between catalyst development, catalyst manufacturing and catalyst users.
NCL and IPCL break Mobilís monopoly: IPCL commercializes a molecular sieve based shape selective catalyst for xylene isomerization at Baroda. This catalyst was at that time a monopoly of one company, namely, Mobil Corporation, USA. This establishes NCL as a foremost center for catalysis research in this part of the world. NCL/CSIR and IPCL jointly fight off an IP challenge by Mobil.
NCL develops a unique process for direct alkylation of benzene with ethanol to produce ethyl benzene, a precursor to styrene. This process is commercialized at Hindustan Polymers at Vishakapatnam.
NCL pioneers the Tissue Culture processes. The first protocols for in vitro culture of plants were established at NCL. Several micropropagation technologies are developed and transferred to industry, namely, cardamom, eucalyptus, bamboo, teak, salvadora, sugarcane, banana, turmeric and ginger, NCL gives birth to a new industry. Tissue culture industry grows and matures by late 1990ís.
NCLís contributions to polymer melt rheology, non-Newtonian fluid mechanics and fundamental advances in polymer reaction engineering creates new understanding on modeling and prediction of the behaviour of industrial reactors producing polyesters. The know-how is practiced in several industries in India.